methylprednisolone acetate has been researched along with Day Blindness in 3 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ober, MD | 1 |
Del Priore, LV | 1 |
Tsai, J | 1 |
Lopez, R | 1 |
Lobes, LA | 1 |
Puklin, JE | 1 |
Young, T | 1 |
Cousins, MJ | 1 |
Andrew, NC | 1 |
Gregor, ZJ | 1 |
3 other studies available for methylprednisolone acetate and Day Blindness
Article | Year |
---|---|
Diagnostic and therapeutic challenges.
Topics: Adolescent; Anemia; Anti-Inflammatory Agents; Cardiomyopathies; Epoetin Alfa; Erythropoietin; Fluore | 2006 |
An additional dimension to the efficacy of epidural steroids.
Topics: Anti-Inflammatory Agents; Arterioles; Deafness; Humans; Injections, Epidural; Methylprednisolone; Me | 2000 |
Intraocular injection of depomedrone.
Topics: Aged; Anti-Inflammatory Agents; Electroretinography; Female; Humans; Injections; Methylprednisolone; | 1986 |